AOD-9604 (Advanced Obesity Drug) was originally developed by Professor Frank Ng at Monash University in Australia in the 1990s, with the intent of finding an anti-obesity drug that had powerful fat burning effects of human growth hormone (HGH) without the muscle-building effect.
AOD-9604 peptide is considered the most potent fat loss peptide supplements.
BIOV8 uses only premium pharmaceutical grade in all of our products.
AOD-9604 peptide is considered the most potent fat loss peptide supplements.AOD-9604 (Advanced Obesity Drug) according to clinical studies, has it’s remarkable power found in its ability to regulate your body's metabolism. By stimulating the metabolism's natural fat-burning process, it triggers the release of fat from obese fat cells, while also working to decrease the growth of new fat in the surrounding fat cells. It works by mimicking the way natural growth hormone regulates fat metabolism without the adverse effects on blood sugar. AOD-9604 stimulates lipolysis (the breakdown of fat) and inhibits lipogenisis (the transformation of non-fat food materials into body fat).
Studies undertake byMonash University discovered the fat-reducing effects of the AOD-9604 appear to be controlled by a small region near one end of the Growth Hormone molecule, stimulating the breakdown of fat. Widely considered a powerful fat loss peptide without harmful side effects.
AOD-9604 peptide possesses many other regenerative properties associated with growth hormone. Currently trials are underway to show the application of AOD-9604 in osteoarthritis, Hypercholesterolemia, bone and cartilage repair. AOD-9604 has an excellent safety profile, recently obtaining Human GRAS status in the USA.
AOD-9604 does not increase appetite or raise cortisol, unlike the GHRP family (GHRP-6, GHRP-2 or Hexarelin)
AOD-9604 promotes the fat loss effects exhibited those received from growth hormone supplementation. At the same time it does not increase food consumption, blood sugar or insulin resistance. (Heffernan 2001, Heffernan 2001, Ng 2000). AOD-9604 stimulates fat breakdown (lipolysis) and fat burning (oxidation), through a mechanism that doesn’t use the hGh receptor.
One theory suggests that there is an unidentified AOD-9604 receptor located on fat cells and that a similar molecule is one of the peptides released by the pituitary somatroph cell when it releases Growth Hormone. Multiple lab studies suggest that AOD-9604 triggers and favours the release of fat from obese fat cells more than those that are lean. This reduces the accumulation of new fat in all fat cells and increases fat burning. The exceptional function of this fat loss peptide is its ability to reduce visceral fat stores. Visceral fat is the abdominal fat that gets deposited throughout the abdomen, blanketing and smothering vital organs.
Purity: >98% (HPLC on request)
Content: 1200mcg/ml subcutaneous injectable provided in a 5ml vial.
Suggested dosage: Inject 0.25ml subcutaneously in the morning daily then enjoy a solid cardio session. Up to 40 days per cycle
Transdermal Option: 300mcg/mL x 50mL - Apply 1mL daily for 40 days.
AOD-9604 is a modified peptide fragment of HGH known as GH Frag 176-191 or AOD-9604. AOD-9604 is a peptide fragment of the C-terminus of hGH. AOD-9604
Molecular Formula: C78H123N23O23S2
AOD-9604 was initially developed in the 1990’s by Professor Frank Ng at Monash University in Australia. The intended purpose for AOD-9604 was to act as one of the best anti-obesity drugs which had the fat burning effects of (HGH) without the coinciding muscle-building effects.
Safety and Tolerability of the Hexadecapeptide AOD-9604 in Humans Heike Stier, Evert Vos, David Kenley (http://www.jofem.org/index.php/jofem/article/view/157/194)
Background: AOD-9604 is a safe peptide fragment of the C-terminus of the hGH molecule that provides activity related to fat loss. In this study, AOD-9604 and its safety data, obtained in clinical trials are reviewed. Methods: There were a total of six trials performed with AOD-9604, all of which were randomised, double-blind and placebo-controlled. The study (AOD9604 peptide review) aimed to identify whether the undesired effects, typically associated with hGH treatment were presented with AOD-9604 treatment. The side effects: increased IGF-1 levels, insulin resistance, impaired glucose tolerance. Blood samples were analysed to identify the presence of anti-AOD-9604 antibodies, to dismiss immunogenicity.
Results: Product AOD-9604 (AOD9604 peptide review) research did not affect serum IGF-1 levels. AOD 9604 does not have an adverse effect on carbohydrate metabolism. Patients showed no presence of anti-AOD -9604 antibodies No withdrawal effects noted No serious adverse events related to AOD 9604 intake. Conclusion: AOD-9604 was shown to have a very good safety, and a safe tolerability profile and treatment did not result in any of the adverse effects seen in full – length hGH treatments
AOD-9604 clinical library. Product Research shows:
AOD-9604 new articles
Metabolic develops profitable marketing plans for AOD-9604
https://technicality.me/2014/02/05/metabolic-develops- profitable-marketing- plans-for- aod-9604/
The internet is full of counterfeit peptides and products of inferior quality. BIOV8 is committed to providing only the highest quality pharmaceutical grade products and can provide proof of purity and sterility results. BIOV8 peptides are only prescribed by one of our qualified licensed practitioners which is required by law.
*** Please note. All injectables come with a 50 pack of syringes. If you're purchasing a vial we recommend purchasing a sharpies box for safe disposal. Buy as a single unit or in a bundle***